BioCardia, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price
BioCardia, Inc. (BCDA) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price of $0.23 per share for the 9-month period ending 2016-09-30, per its 10-Q filed 2016-10-17.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice · last filed 2016-10-17
- BioCardia, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for the quarter ending 2016-03-31 was $0.00.
- BioCardia, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for the quarter ending 2015-03-31 was $0.00.
- BioCardia, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for the quarter ending 2014-03-31 was $0.00.
- BioCardia, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for the quarter ending 2013-03-31 was $0.00.
- BioCardia, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for fiscal 2015 was $0.00.
- BioCardia, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for fiscal 2014 was $0.00.
- BioCardia, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for fiscal 2013 was $0.00.
- BioCardia, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for fiscal 2012 was $0.00, a 100.00% decline from fiscal 2011.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price 12 month |
|---|---|---|---|---|
| 2016-09-30 | $0.23 10-Q · filed 2016-10-17 | |||
| 2016-06-30 | $0.00 10-Q · filed 2016-08-02 | |||
| 2016-03-31 | $0.00 10-Q · filed 2016-05-03 | |||
| 2015-12-31 | $0.00 10-K · filed 2016-03-25 | |||
| 2015-09-30 | $0.00 10-Q · filed 2015-10-29 | |||
| 2015-06-30 | $0.00 10-Q · filed 2015-08-12 | |||
| 2015-03-31 | $0.00 10-Q · filed 2015-05-12 | |||
| 2014-12-31 | $0.00 10-K · filed 2015-03-24 | |||
| 2014-09-30 | $0.00 10-Q · filed 2014-11-06 | |||
| 2014-06-30 | $0.00 10-Q · filed 2014-08-06 | |||
| 2014-03-31 | $0.00 10-Q · filed 2014-05-12 | |||
| 2013-12-31 | $0.00 10-K · filed 2014-03-24 | |||
| 2013-09-30 | $0.00 10-Q · filed 2013-11-01 | |||
| 2013-06-30 | $0.00 10-Q · filed 2013-07-26 | |||
| 2013-03-31 | $0.00 10-Q · filed 2013-05-10 | |||
| 2012-12-31 | $0.00 10-K · filed 2014-03-24 | |||
| 2012-09-30 | $0.00 10-Q · filed 2012-11-08 | |||
| 2012-06-30 | $0.00 10-Q · filed 2012-08-10 | |||
| 2011-12-31 | $0.23 10-K · filed 2013-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |